Gipamed Study: Validation of a Notification Grid for Pharmaceutical Self-Medication Interventions - Université Clermont Auvergne Accéder directement au contenu
Article Dans Une Revue International Journal of Pharma Sciences and Scientific Research Année : 2020

Gipamed Study: Validation of a Notification Grid for Pharmaceutical Self-Medication Interventions

Résumé

Self-medication can present risks that can result in pharmacists carrying out pharmaceutical interventions (PI). Aim: (i) create a PI notification grid adapted to self-medication (ii) validate it and (iii) analyze the reasons for PIs generated by spontaneous requests from patients in community pharmacies. Method: the study was conducted in 140 community pharmacies in the Auvergne Rhône Alpes region for 3 non-consecutive weeks in 2017 and 2018. Each PI has been notified using a standardized and specifically developed grid. The validity of the internal and external structure of the grid was assessed. Results: 1519 self-medicated PIs were reported. The notification grid was validated with a near perfect match (kappa coefficient 0.94). Overall, the community pharmacists found it to be comprehensive, useful, clear and easy to use. Four ATC classes accounted for nearly 80% of the PIs (respiratory system, nervous system, muscle and skeleton, digestive tract and metabolism). Almost 1/3 of the PIs were generated by requests for prescription-only medicines, followed by optional prescription medicines not indicated for symptomatology and those contraindicated with the pathophysiological status. In most instances, the community pharmacist proposed a therapeutic alternative and/or referred for medical consultation; the proposed solution was accepted in more than 90% of cases. Conclusion: The GIPAMED study facilitated the creation and validation of a specific notification grid for self-medication PIs. It also raises the question of the level of risk avoided through the intervention of the community pharmacist Abstract Introduction
Fichier principal
Vignette du fichier
GIPAMED-Study-Validation-of-a-Notification-Grid-for-Pharmaceutical-Self-Medication-Interventions.pdf (329.67 Ko) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte
Loading...

Dates et versions

hal-02892625 , version 1 (07-07-2020)

Licence

Paternité - Pas d'utilisation commerciale - Pas de modification

Identifiants

  • HAL Id : hal-02892625 , version 1

Citer

Chantal Savanovitch, Céline Prunet-Spano, Olivier Catala, Sabrina Bedhomme, Elodie Lafarge, et al.. Gipamed Study: Validation of a Notification Grid for Pharmaceutical Self-Medication Interventions. International Journal of Pharma Sciences and Scientific Research, 2020, 6 (1), pp.1-7. ⟨hal-02892625⟩
176 Consultations
213 Téléchargements

Partager

Gmail Facebook X LinkedIn More